Silexion Therapeutics Corp SLXN
1.31 USD -0.19 (-12.67%)
Regular-session close
1.25 -0.06 -4.58%
After hours · Nov 20, 7:40 PM ET
1.30 Day range 1.40
1.26 52-week range 777.12
- YTD
- -99.72%
- 1 year
- -99.77%
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Silexion Therapeutics (NASDAQ:SLXN) stock rose 11.8% to $1.61 during Wednesday's after-market session. The market value of their outstanding shares is at $1.0 million. As per the news, the Q3…
globenewswire.com Silexion Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update First patient dosed in the Phase 2/3 clinical trial of SIL204 in locally advanced pancreatic cancer at Tel Aviv Sourasky Medical Center, moving SIL204 into active patient treatmentbenzinga.com Silexion Therapeutics Announces 1-For-24 Reverse Share Split, Trading On Split-Adjusted Basis To Begin On November 11 Trading on a split-adjusted basis will begin at market open on November 11, 2026.This adjustment is expected to help Silexion regain compliance with the Nasdaq minimum bid price requirement, enhance…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Pomdoctor (NASDAQ:POM) shares rose 25.6% to $1.47 during Friday's after-market session. The market value of their outstanding shares is at $8.3 million. GeneDx Holdings (NASDAQ:WGS) shares…
